Screening of adults with congenital cardiac disease lost for follow-up

Cardiol Young. 2007 Dec;17(6):601-8. doi: 10.1017/S1047951107001436. Epub 2007 Oct 24.

Abstract

Objective: A problem facing doctors treating adults with congenitally malformed hearts is that a significant number of these patients are lost for follow-up. The purpose of our study is to describe the medical history and clinical findings in a group of such adults that was lost for follow-up. DESIGN, SETTINGS AND PATIENTS: The Danish press ran a front-page story about adults with congenitally malformed hearts who were lost for follow-up. These patients were strongly advised to contact a center for congenital cardiac disease, and we examined all responding patients within four-weeks.

Interventions: We carried out a structured interview, a clinical examination, echocardiography, and measured levels of N-terminal pro brain natriuretic peptide.

Results: The number of responders was 147. Based on the diagnosis and the findings, further follow-up was scheduled for 52 (35.4%), either because of significant residual lesions, found in 32, or the risk of late complications, judged to be present in 20. Symptoms were present in 36.5% of patients scheduled for follow-up. The presence of a heart murmur was highly predictive of the need for further follow-up but the sensitivity was too low to recommend the use of auscultation as a screening test.

Conclusion: A large proportion of adults with congenitally malformed hearts who are lost for follow-up require regular assessment according to a modern standard. Symptoms, signs, and measurement of natriuretic peptide cannot replace full cardiological assessment. It is a challenge for centres treating adults with congenital heart disease to find the lost group of patient with significant cardiac malformations.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Auscultation / methods*
  • Biomarkers / blood
  • Denmark / epidemiology
  • Disease Progression
  • Echocardiography / methods*
  • Female
  • Follow-Up Studies
  • Heart Defects, Congenital / blood
  • Heart Defects, Congenital / diagnosis*
  • Heart Defects, Congenital / epidemiology
  • Humans
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Natriuretic Peptide, Brain / blood*
  • Patient Compliance*
  • Prevalence
  • Prognosis
  • Retrospective Studies
  • Severity of Illness Index
  • Time Factors

Substances

  • Biomarkers
  • Natriuretic Peptide, Brain